Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
26.43
-1.44 (-5.17%)
Nov 20, 2026, 3:00 PM CST
SHA:603983 Revenue
Guangdong Marubi Biotechnology had revenue of 571.85M CNY in the quarter ending September 30, 2026, a decrease of -16.61%. This brings the company's total for the last twelve months to 3.24B, down -6.46% year-over-year. In the year 2025, Guangdong Marubi Biotechnology had annual revenue of 3.46B with 16.48% growth. That makes Guangdong Marubi Biotechnology the 11,440th largest company in the world by revenue and 1,925th in China.
Revenue (ttm)
3.24B
Revenue Growth
-6.46%
P/S Ratio
3.27
Revenue / Employee
2.35M
Employees
1,380
Market Cap
10.60B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.46B | 489.55M | 16.48% |
| Dec 31, 2024 | 2.97B | 744.18M | 33.44% |
| Dec 31, 2023 | 2.23B | 493.88M | 28.52% |
| Dec 31, 2022 | 1.73B | -55.31M | -3.10% |
| Dec 31, 2021 | 1.79B | 42.04M | 2.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Proya Cosmetics | 11.13B |
| C&S Paper Co.,Ltd | 8.81B |
| Shanghai Jahwa United | 6.72B |
| Yunnan Botanee Bio-Technology Group Co.LTD | 5.53B |
| Shanghai Flyco Electrical Appliance | 3.89B |
| Lushang Freda Pharmaceutical | 3.83B |
| Chongqing Baiya Sanitary Products | 3.56B |
| Harbin Fuerjia Technology | 2.37B |